Leng Q - Search Results

1

Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer.

Tang D, He J, Dai Y, Geng X, Leng Q, Jiang H, Sun R, Xu S. Tang D, et al. Among authors: leng q. Cancer Gene Ther. 2022 May;29(5):543-557. doi: 10.1038/s41417-021-00332-6. Epub 2021 Apr 14. Cancer Gene Ther. 2022. Retraction in: Cancer Gene Ther. 2023 Oct;30(10):1442. doi: 10.1038/s41417-023-00669-0. PMID: 33854217 Retracted.

2

Systemic delivery of HK Raf-1 siRNA polyplexes inhibits MDA-MB-435 xenografts.

Leng Q, Scaria P, Lu P, Woodle MC, Mixson AJ. Leng Q, et al. Cancer Gene Ther. 2008 Aug;15(8):485-95. doi: 10.1038/cgt.2008.29. Epub 2008 May 16. Cancer Gene Ther. 2008. PMID: 18483501 Free PMC article.

3

Selective modification of HK peptides enhances siRNA silencing of tumor targets in vivo.

Chou ST, Leng Q, Scaria P, Woodle M, Mixson AJ. Chou ST, et al. Among authors: leng q. Cancer Gene Ther. 2011 Oct;18(10):707-16. doi: 10.1038/cgt.2011.40. Epub 2011 Aug 5. Cancer Gene Ther. 2011. PMID: 21818135 Free PMC article.

4

Targeting the KDM4B-AR-c-Myc axis promotes sensitivity to androgen receptor-targeted therapy in advanced prostate cancer.

Tang DE, Dai Y, He JX, Lin LW, Leng QX, Geng XY, Fu DX, Jiang HW, Xu SH. Tang DE, et al. J Pathol. 2020 Oct;252(2):101-113. doi: 10.1002/path.5495. Epub 2020 Aug 28. J Pathol. 2020. PMID: 32617978

5

Location of a single histidine within peptide carriers increases mRNA delivery.

He J, Xu S, Leng Q, Mixson AJ. He J, et al. Among authors: leng q. J Gene Med. 2021 Feb;23(2):e3295. doi: 10.1002/jgm.3295. Epub 2020 Dec 21. J Gene Med. 2021. PMID: 33171540 Free PMC article.

6

pH-Sensitive Targeting of Tumors with Chemotherapy-Laden Nanoparticles: Progress and Challenges.

Imtiyaz Z, He J, Leng Q, Agrawal AK, Mixson AJ. Imtiyaz Z, et al. Among authors: leng q. Pharmaceutics. 2022 Nov 10;14(11):2427. doi: 10.3390/pharmaceutics14112427. Pharmaceutics. 2022. PMID: 36365245 Free PMC article. Review.

7

Retraction Note: Targeting KDM1B-dependent miR-215-AR-AGR2-axis promotes sensitivity to enzalutamide-resistant prostate cancer.

Tang D, He J, Dai Y, Geng X, Leng Q, Jiang H, Sun R, Xu S. Tang D, et al. Among authors: leng q. Cancer Gene Ther. 2023 Oct;30(10):1442. doi: 10.1038/s41417-023-00669-0. Cancer Gene Ther. 2023. PMID: 37735565 No abstract available.

8

Delivery of mRNA with Histidine-Lysine Peptides.

Leng Q, He J, Anand A, Mixson AJ. Leng Q, et al. Methods Mol Biol. 2024;2822:367-386. doi: 10.1007/978-1-0716-3918-4_23. Methods Mol Biol. 2024. PMID: 38907929

9

Highly branched HK peptides are effective carriers of siRNA.

Leng Q, Scaria P, Zhu J, Ambulos N, Campbell P, Mixson AJ. Leng Q, et al. J Gene Med. 2005 Jul;7(7):977-86. doi: 10.1002/jgm.748. J Gene Med. 2005. PMID: 15772938

10

Small interfering RNA targeting Raf-1 inhibits tumor growth in vitro and in vivo.

Leng Q, Mixson AJ. Leng Q, et al. Cancer Gene Ther. 2005 Aug;12(8):682-90. doi: 10.1038/sj.cgt.7700831. Cancer Gene Ther. 2005. PMID: 15803144

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

306 results

Search Page

Filters